Detalhe da pesquisa
1.
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.
Br J Haematol
; 204(5): 2049-2056, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38343073
2.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Blood
; 138(7): 571-583, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33889952
3.
Health-related quality of life in patients with ß-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept.
Eur J Haematol
; 111(1): 113-124, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37095595
4.
Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network.
Ann Hematol
; 100(5): 1139-1147, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33742225
5.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37222267
6.
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Am J Hematol
; 92(10): 1037-1046, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28675513
7.
Patient-reported outcomes in Hodgkin lymphoma trials: a systematic review.
Front Oncol
; 14: 1353101, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38544841
8.
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.
Ann Hematol
; 92(1): 25-32, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22983750
9.
Understanding Quality of Life in Patients With Acute Leukemia, a Global Survey.
J Patient Cent Res Rev
; 10(1): 21-30, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36714002
10.
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials.
Cancers (Basel)
; 15(24)2023 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38136310
11.
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE).
Cancers (Basel)
; 15(9)2023 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37173908
12.
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).
J Clin Oncol
; 41(28): 4486-4496, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37294914
13.
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
J Clin Oncol
; 41(15): 2827-2842, 2023 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36930857
14.
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study.
Ann Hematol
; 91(4): 527-32, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21964878
15.
Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective.
J Blood Med
; 13: 327-335, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35747742
16.
The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review.
Cancers (Basel)
; 14(23)2022 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36497488
17.
Does Etelcalcetide reverse myelofibrotic bone changes due to hyperparathyroidism? A case report.
Front Med (Lausanne)
; 9: 1050062, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36910010
18.
A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes.
J Clin Med
; 11(3)2022 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35160344
19.
Relationship between Serum Ferritin and Outcomes in ß-Thalassemia: A Systematic Literature Review.
J Clin Med
; 11(15)2022 Jul 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35956067
20.
A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.
Am J Blood Res
; 11(4): 325-360, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34540343